RISO-KAGAKU-CORPORATION
RISO KAGAKU CORPORATION (President & CEO: Akira Hayama; hereinafter “RISO”) announced today the launch of VALEZUS, a new brand of high-speed ink-jet printers for the production-printing market. RISO will start with successive rollouts worldwide of the new brand’s first product, the VALEZUS T2100, a high-speed, 320-page-per-minute (320-ppm) cut-sheet printer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190818005001/en/
One of RISO’s commanding strengths is the development of inks optimized for high-speed paper feeding and high-speed printing. This expertise enables RISO to deliver unique printing solutions serving the demand for high-volume printing. With technologies developed and cultivated in this field, RISO launches the VALEZUS, a fresh brand targeting the production-printing market.
2 The all-new VALEZUS T2100
VALEZUS T2100
The first product of the new brand, the VALEZUS T2100 is a high-speed full-color cut-sheet inkjet printer. By connecting printer engines to print the front and back-side respectively, the VALEZUS T2100 achieves a blazing-fast double-sided printing speed of 320ppm. The VALEZUS T2100 offers a compact footprint for a production printer as well as superior ease of use and maintenance.
With these features, the VALEZUS T2100 increases productivity and dramatically improves work efficiency in high-volume printing.
In high-volume printing applications, such as transactional printing at print service providers, in-house printing at financial institutions, insurance companies and government offices, the VALEZUS T2100 opens a world of new possibilities in cut-sheet printing.
RISO will show the VALEZUS T2100 at the following exhibitions:
“The Print Show 2019” from September 17 to 19 in Birmingham, United Kingdom.
“PRINTING United 2019” from October 23 to 25 in Dallas, Texas, United States.
You can view a 1-minute promotional video about this product here. https://youtu.be/bpzQLYe1Z54
Product name and launch period
Product name |
VALEZUS T2100 |
Launch period |
Fall 2019 |
Rollout will begin in North America and Europe. Launch dates in Japan and elsewhere in Asia are to be determined.
Main features of the VALEZUS T2100
High Productivity
1) Capable of 320ppm high speed cut sheet printing
The VALEZUS T2100 can print 320ppm*1 or 19,200 pages per hour*2 , based on full-color, double-sided printing of A4-sized paper. Because the VALEZUS T2100 is a cut sheet printer, it can easily handle short-run jobs as well, enabling speedy processing of a diverse range of jobs.
*1 Continuous printing of A4-sized paper with long-edge feed on standard settings
*2 Not including cleaning time
2) Incorporation of newly developed high-capacity feeder/stacker units that enable paper loading/unloading during continuous printing
The VALEZUS T2100 is equipped with two high-capacity feeder/stacker units, each capable of feeding and stacking up to 4,000 sheets (total of 8,000 sheets). The two units can be switched while the printer is active, allowing users to load/unload paper without stopping the job. Also, the stacker unit is equipped with a jogger mechanism and dedicated cart, enabling smooth transition to post-processing after printing.
* The feeder/stacker units are scheduled to be available in the spring of 2020.
3) Compatible with PDF, PostScript® as well as AFP/IPDS
The VALEZUS T2100 can fit in existing workflow of customers. It supports PDF and Postscript, generally used in an open system environment as well as AFP/IPDS, which is used as an industry standard for mission-critical production print applications.
4) Oil-based ink complements environmentally-conscious printing by low energy consumption
The VALEZUS T2100 incorporates an inkjet system that adopts oil-based inks ensuring energy-saving operation. Oil-based inks contribute to energy-saving because there is no need for ink-drying heaters required for water-based inks, and unlike toner-based technologies, there is no heat-fixing process required.
Specifications
ITEM |
Description |
|
Print Type |
Line-type inkjet system (drop on-demand) |
|
Ink Type |
Oil-based pigment ink (Cyan, Magenta, Yellow, Black, Gray) |
|
Print Speed *1 |
Duplex: 320 ppm, Simplex: 160 ppm (A4 LEF, Letter LEF) |
|
Resolution |
Standard |
Black: 600dpi x 600dpi Cyan/Magenta/Yellow/Gray: 300dpi x 300dpi |
Fine |
Black: 600dpi x 600dpi Cyan/Magenta/Yellow/Gray: 300dpi x 600dpi |
|
Paper Size |
Double Tray Feeder |
Max: 330.2mm x 465mm (13” x 18.3”) Min: 148mm x 210mm (5.9” x 8.3”) |
Feed Tray |
Max: 297mm x 432mm (11.6” x 17.0”) Min: 182mm x 210mm (7.2” x 8.3”) |
|
Paper Weight |
Double Tray Feeder |
46gsm to 210gsm (12-lb bond to 56-lb bond) |
Feed Tray |
52gsm to 104gsm (14-lb bond to 28-lb bond) |
|
Paper Tray Capacity |
Double Tray Feeder |
4,000 sheets x 2 trays*2 (Height up to 440mm [17.3”]) |
Feed Tray |
500 sheets x 3 trays*2 (Height up to 56mm [2.2”]) |
|
Output Tray Capacity |
Double Tray Stacker |
4,000 sheets x 2 trays *2 *3 (Height up to 440mm [17.3”]) |
Power Consumption |
Max. 3,010W |
|
Dimensions (W x D x H) |
4,755mm x 750mm x 1,445mm (187.2” x 29.6” x 56.9”) |
|
*1 When using plain paper and recycled paper (85 gsm [23-lb bond]), and standard density setting.
*2 When using plain paper and recycled paper (85 gsm [23-lb bond]).
*3 When short edge is less than 182mm or long edge is less than 257mm, Max capacity is 1,000 sheets.
Specifications are subject to change without notice.
Symbol mark, logo mark and VALEZUS are trademarks or registered trademarks of RISO KAGAKU CORPORATION. Adobe and PostScript are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries. Other corporate names and/or trademarks are either registered trademarks or trademarks of each company, respectively.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190818005001/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
